³Ô¹ÏÍø

Make scientific figures in minutes

Create publication-quality figures with pre-made icons and templates, all from ³Ô¹ÏÍø's web-based scientific illustration software

search icon

Try a synonym, or to request an icon from the app.

Telocyte (with vesicles)

Telocyte (with vesicles) - Editable icon of a telocyte cell as an irregularly shaped cell body with nucleus and 3 long telopodes with enlarged segmented podoms and vesicles undergoing exo and endocytosis
[{"image":"https://icons.biorender.com/w75xh75/66325f93a51fc127a42a0410/66325f24a51fc127a42a0363.png","waterMarkImage":"https://icons.biorender.com/w550xh620/66325f93a51fc127a42a0410/66325f24a51fc127a42a0363.png"},{"image":"https://icons.biorender.com/w75xh75/66325f93a51fc127a42a0411/66325f24a51fc127a42a0363.png","waterMarkImage":"https://icons.biorender.com/w550xh620/66325f93a51fc127a42a0411/66325f24a51fc127a42a0363.png"},{"image":"https://icons.biorender.com/w75xh75/66325f93a51fc127a42a0412/66325f24a51fc127a42a0363.png","waterMarkImage":"https://icons.biorender.com/w550xh620/66325f93a51fc127a42a0412/66325f24a51fc127a42a0363.png"},{"image":"https://icons.biorender.com/w75xh75/66325f93a51fc127a42a0413/66325f24a51fc127a42a0363.png","waterMarkImage":"https://icons.biorender.com/w550xh620/66325f93a51fc127a42a0413/66325f24a51fc127a42a0363.png"},{"image":"https://icons.biorender.com/w75xh75/66325f93a51fc127a42a0414/66325f24a51fc127a42a0363.png","waterMarkImage":"https://icons.biorender.com/w550xh620/66325f93a51fc127a42a0414/66325f24a51fc127a42a0363.png"},{"image":"https://icons.biorender.com/w75xh75/66325f93a51fc127a42a0415/66325f24a51fc127a42a0363.png","waterMarkImage":"https://icons.biorender.com/w550xh620/66325f93a51fc127a42a0415/66325f24a51fc127a42a0363.png"},{"image":"https://icons.biorender.com/w75xh75/66325f93a51fc127a42a0416/66325f24a51fc127a42a0363.png","waterMarkImage":"https://icons.biorender.com/w550xh620/66325f93a51fc127a42a0416/66325f24a51fc127a42a0363.png"},{"image":"https://icons.biorender.com/w75xh75/66325f93a51fc127a42a0417/66325f24a51fc127a42a0363.png","waterMarkImage":"https://icons.biorender.com/w550xh620/66325f93a51fc127a42a0417/66325f24a51fc127a42a0363.png"},{"image":"https://icons.biorender.com/w75xh75/66325f93a51fc127a42a0418/66325f24a51fc127a42a0363.png","waterMarkImage":"https://icons.biorender.com/w550xh620/66325f93a51fc127a42a0418/66325f24a51fc127a42a0363.png"},{"image":"https://icons.biorender.com/w75xh75/66325f93a51fc127a42a0419/66325f24a51fc127a42a0363.png","waterMarkImage":"https://icons.biorender.com/w550xh620/66325f93a51fc127a42a0419/66325f24a51fc127a42a0363.png"},{"image":"https://icons.biorender.com/w75xh75/66325f93a51fc127a42a041a/66325f24a51fc127a42a0363.png","waterMarkImage":"https://icons.biorender.com/w550xh620/66325f93a51fc127a42a041a/66325f24a51fc127a42a0363.png"},{"image":"https://icons.biorender.com/w75xh75/66325f93a51fc127a42a041b/66325f24a51fc127a42a0363.png","waterMarkImage":"https://icons.biorender.com/w550xh620/66325f93a51fc127a42a041b/66325f24a51fc127a42a0363.png"},{"image":"https://icons.biorender.com/w75xh75/66325f93a51fc127a42a041c/66325f24a51fc127a42a0363.png","waterMarkImage":"https://icons.biorender.com/w550xh620/66325f93a51fc127a42a041c/66325f24a51fc127a42a0363.png"},{"image":"https://icons.biorender.com/w75xh75/66325f93a51fc127a42a041d/66325f24a51fc127a42a0363.png","waterMarkImage":"https://icons.biorender.com/w550xh620/66325f93a51fc127a42a041d/66325f24a51fc127a42a0363.png"},{"image":"https://icons.biorender.com/w75xh75/66325f93a51fc127a42a041e/66325f24a51fc127a42a0363.png","waterMarkImage":"https://icons.biorender.com/w550xh620/66325f93a51fc127a42a041e/66325f24a51fc127a42a0363.png"},{"image":"https://icons.biorender.com/w75xh75/66325f93a51fc127a42a041f/66325f24a51fc127a42a0363.png","waterMarkImage":"https://icons.biorender.com/w550xh620/66325f93a51fc127a42a041f/66325f24a51fc127a42a0363.png"},{"image":"https://icons.biorender.com/w75xh75/66325f93a51fc127a42a0420/66325f24a51fc127a42a0363.png","waterMarkImage":"https://icons.biorender.com/w550xh620/66325f93a51fc127a42a0420/66325f24a51fc127a42a0363.png"},{"image":"https://icons.biorender.com/w75xh75/66325f93a51fc127a42a0421/66325f24a51fc127a42a0363.png","waterMarkImage":"https://icons.biorender.com/w550xh620/66325f93a51fc127a42a0421/66325f24a51fc127a42a0363.png"},{"image":"https://icons.biorender.com/w75xh75/66325f93a51fc127a42a0422/66325f24a51fc127a42a0363.png","waterMarkImage":"https://icons.biorender.com/w550xh620/66325f93a51fc127a42a0422/66325f24a51fc127a42a0363.png"},{"image":"https://icons.biorender.com/w75xh75/66325f93a51fc127a42a0423/66325f24a51fc127a42a0363.png","waterMarkImage":"https://icons.biorender.com/w550xh620/66325f93a51fc127a42a0423/66325f24a51fc127a42a0363.png"},{"image":"https://icons.biorender.com/w75xh75/66325f93a51fc127a42a0424/66325f24a51fc127a42a0363.png","waterMarkImage":"https://icons.biorender.com/w550xh620/66325f93a51fc127a42a0424/66325f24a51fc127a42a0363.png"},{"image":"https://icons.biorender.com/w75xh75/66325f93a51fc127a42a0425/66325f24a51fc127a42a0363.png","waterMarkImage":"https://icons.biorender.com/w550xh620/66325f93a51fc127a42a0425/66325f24a51fc127a42a0363.png"},{"image":"https://icons.biorender.com/w75xh75/66325f93a51fc127a42a0426/66325f24a51fc127a42a0363.png","waterMarkImage":"https://icons.biorender.com/w550xh620/66325f93a51fc127a42a0426/66325f24a51fc127a42a0363.png"},{"image":"https://icons.biorender.com/w75xh75/66325f93a51fc127a42a0427/66325f24a51fc127a42a0363.png","waterMarkImage":"https://icons.biorender.com/w550xh620/66325f93a51fc127a42a0427/66325f24a51fc127a42a0363.png"},{"image":"https://icons.biorender.com/w75xh75/66325f93a51fc127a42a0428/66325f24a51fc127a42a0363.png","waterMarkImage":"https://icons.biorender.com/w550xh620/66325f93a51fc127a42a0428/66325f24a51fc127a42a0363.png"},{"image":"https://icons.biorender.com/w75xh75/66325f93a51fc127a42a0429/66325f24a51fc127a42a0363.png","waterMarkImage":"https://icons.biorender.com/w550xh620/66325f93a51fc127a42a0429/66325f24a51fc127a42a0363.png"},{"image":"https://icons.biorender.com/w75xh75/66325f93a51fc127a42a042a/66325f24a51fc127a42a0363.png","waterMarkImage":"https://icons.biorender.com/w550xh620/66325f93a51fc127a42a042a/66325f24a51fc127a42a0363.png"},{"image":"https://icons.biorender.com/w75xh75/66325f93a51fc127a42a042b/66325f24a51fc127a42a0363.png","waterMarkImage":"https://icons.biorender.com/w550xh620/66325f93a51fc127a42a042b/66325f24a51fc127a42a0363.png"},{"image":"https://icons.biorender.com/w75xh75/66325f93a51fc127a42a042c/66325f24a51fc127a42a0363.png","waterMarkImage":"https://icons.biorender.com/w550xh620/66325f93a51fc127a42a042c/66325f24a51fc127a42a0363.png"},{"image":"https://icons.biorender.com/w75xh75/66325f93a51fc127a42a042d/66325f24a51fc127a42a0363.png","waterMarkImage":"https://icons.biorender.com/w550xh620/66325f93a51fc127a42a042d/66325f24a51fc127a42a0363.png"},{"image":"https://icons.biorender.com/w75xh75/66325f93a51fc127a42a042e/66325f24a51fc127a42a0363.png","waterMarkImage":"https://icons.biorender.com/w550xh620/66325f93a51fc127a42a042e/66325f24a51fc127a42a0363.png"},{"image":"https://icons.biorender.com/w75xh75/66325f93a51fc127a42a042f/66325f24a51fc127a42a0363.png","waterMarkImage":"https://icons.biorender.com/w550xh620/66325f93a51fc127a42a042f/66325f24a51fc127a42a0363.png"},{"image":"https://icons.biorender.com/w75xh75/66325f93a51fc127a42a0430/66325f24a51fc127a42a0363.png","waterMarkImage":"https://icons.biorender.com/w550xh620/66325f93a51fc127a42a0430/66325f24a51fc127a42a0363.png"},{"image":"https://icons.biorender.com/w75xh75/66325f93a51fc127a42a0431/66325f24a51fc127a42a0363.png","waterMarkImage":"https://icons.biorender.com/w550xh620/66325f93a51fc127a42a0431/66325f24a51fc127a42a0363.png"},{"image":"https://icons.biorender.com/w75xh75/66325f93a51fc127a42a0432/66325f24a51fc127a42a0363.png","waterMarkImage":"https://icons.biorender.com/w550xh620/66325f93a51fc127a42a0432/66325f24a51fc127a42a0363.png"},{"image":"https://icons.biorender.com/w75xh75/66325f93a51fc127a42a0433/66325f24a51fc127a42a0363.png","waterMarkImage":"https://icons.biorender.com/w550xh620/66325f93a51fc127a42a0433/66325f24a51fc127a42a0363.png"},{"image":"https://icons.biorender.com/w75xh75/66325f93a51fc127a42a0434/66325f24a51fc127a42a0363.png","waterMarkImage":"https://icons.biorender.com/w550xh620/66325f93a51fc127a42a0434/66325f24a51fc127a42a0363.png"},{"image":"https://icons.biorender.com/w75xh75/66325f93a51fc127a42a0435/66325f24a51fc127a42a0363.png","waterMarkImage":"https://icons.biorender.com/w550xh620/66325f93a51fc127a42a0435/66325f24a51fc127a42a0363.png"},{"image":"https://icons.biorender.com/w75xh75/66325f93a51fc127a42a0436/66325f24a51fc127a42a0363.png","waterMarkImage":"https://icons.biorender.com/w550xh620/66325f93a51fc127a42a0436/66325f24a51fc127a42a0363.png"},{"image":"https://icons.biorender.com/w75xh75/66325f93a51fc127a42a0437/66325f24a51fc127a42a0363.png","waterMarkImage":"https://icons.biorender.com/w550xh620/66325f93a51fc127a42a0437/66325f24a51fc127a42a0363.png"},{"image":"https://icons.biorender.com/w75xh75/66325f93a51fc127a42a0438/66325f24a51fc127a42a0363.png","waterMarkImage":"https://icons.biorender.com/w550xh620/66325f93a51fc127a42a0438/66325f24a51fc127a42a0363.png"},{"image":"https://icons.biorender.com/w75xh75/66325f93a51fc127a42a0439/66325f24a51fc127a42a0363.png","waterMarkImage":"https://icons.biorender.com/w550xh620/66325f93a51fc127a42a0439/66325f24a51fc127a42a0363.png"},{"image":"https://icons.biorender.com/w75xh75/66325f93a51fc127a42a043a/66325f24a51fc127a42a0363.png","waterMarkImage":"https://icons.biorender.com/w550xh620/66325f93a51fc127a42a043a/66325f24a51fc127a42a0363.png"},{"image":"https://icons.biorender.com/w75xh75/66325f93a51fc127a42a043b/66325f24a51fc127a42a0363.png","waterMarkImage":"https://icons.biorender.com/w550xh620/66325f93a51fc127a42a043b/66325f24a51fc127a42a0363.png"},{"image":"https://icons.biorender.com/w75xh75/66325f93a51fc127a42a043c/66325f24a51fc127a42a0363.png","waterMarkImage":"https://icons.biorender.com/w550xh620/66325f93a51fc127a42a043c/66325f24a51fc127a42a0363.png"},{"image":"https://icons.biorender.com/w75xh75/66325f93a51fc127a42a043d/66325f24a51fc127a42a0363.png","waterMarkImage":"https://icons.biorender.com/w550xh620/66325f93a51fc127a42a043d/66325f24a51fc127a42a0363.png"},{"image":"https://icons.biorender.com/w75xh75/66325f93a51fc127a42a043e/66325f24a51fc127a42a0363.png","waterMarkImage":"https://icons.biorender.com/w550xh620/66325f93a51fc127a42a043e/66325f24a51fc127a42a0363.png"},{"image":"https://icons.biorender.com/w75xh75/66325f93a51fc127a42a043f/66325f24a51fc127a42a0363.png","waterMarkImage":"https://icons.biorender.com/w550xh620/66325f93a51fc127a42a043f/66325f24a51fc127a42a0363.png"},{"image":"https://icons.biorender.com/w75xh75/66325f93a51fc127a42a0440/66325f24a51fc127a42a0363.png","waterMarkImage":"https://icons.biorender.com/w550xh620/66325f93a51fc127a42a0440/66325f24a51fc127a42a0363.png"},{"image":"https://icons.biorender.com/w75xh75/66325f93a51fc127a42a0441/66325f24a51fc127a42a0363.png","waterMarkImage":"https://icons.biorender.com/w550xh620/66325f93a51fc127a42a0441/66325f24a51fc127a42a0363.png"}]
Keywords
telocyte,tc,tcs,telopode,podom,cell,nucleus,podomer,interstitial cell,stromal cell,iclc,ic,prolongation,stroma,alzheimer's,alzheimer's disease,cell development,angiogenesis,cell adhesion,electrical response,cell cycle,apoptosis,intercellular communication,heterogeneity,pathogenesis,wnt/b-catenin,signalling pathway,tissue repair,tissue regeneration,exosome,ectosome,microvesicle,vesicle,endosome,apoptotic body,mrna,stem cell,endothelial cell,cardiomyocyte,cm,subepicardium,organ cell,pathology,lood vessel,nerve ending,regenerative medicine,cell biology,histology,immunology,cardiology,pulmonology,gastroenterology,neuroscience,pharmacology,tc,insterstitial cell,vesicle

Join 1,500,000 other scientists on ³Ô¹ÏÍø

Sign up for your free account and start creating scientific figures faster today
Decorative Chat Icon

FAQ

What is ³Ô¹ÏÍø?
³Ô¹ÏÍø is a web-based software that helps you create scientific figures in minutes. Our program has a library of more than 30,000 life science icons, as well as drag-and-drop functionality to help you make professional figures quickly.
How can I use this icon?
You can use this icon and thousands more by signing up for a ³Ô¹ÏÍø account at https://app.biorender.com
I want a variation of this icon. How do I know if it's available?
You can browse our library by typing in the search bar above or sign up for ³Ô¹ÏÍø and search in the app. Can't find an icon? Premium users can request custom icons and we'll make them in as little as 48 hours.
Where can I use figures I make with this icon?
Figures made in ³Ô¹ÏÍø can always be used for educational use. If you'd like to use a figure for a publication, you must be registered for a premium plan. You can find more details on our pricing page
I have other questions. How do I contact support?
You can contact us anytime at support@biorender.com. We aim to get back to all requests within 24 hours.

Looking for science content?

Browse 50K+ icons and templates that are peer-reviewed, easy to use, and free.